Published in Lab Business Week, July 23rd, 2006
Current year results include a one time gain of $2.4 million (12 cents per share) on the sale of the company's rapid cardiac test business in the fourth quarter.
Revenues for the year were $7.3 million, a drop of $2.7 million from last year. Rapid cardiac test sales were $4.3 million compared to $7.1 million in 2005. This decline was attributable to a continuing trend of lower sales volumes and to the sale of the rapid cardiac business...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.